Executive Vice President and Head, Malaria Initiative, responsible for developing and executing strategies to maintain Novartis leadership in malaria control and elimination. Previously, Vice President, New Products and Portfolio Strategy in Novartis Oncology, leading the commercial development of new drug candidates, and evaluation of in-licensing and M&A opportunities. Also served as Executive Director, New Products and Disease Strategy. Before Joining Novartis Oncology in 2001, was Director, Global Marketing and Director, Regulatory Affairs at Bristol-Myers Squibb; Research Scientist at Merck. BS University of Ife, Nigeria; PhD University of British Columbia, Vancouver; and MBA Wharton School, University of Pennsylvania.